BridgeBio Pharma, Inc. (BBIO)
67.25
+0.34
(+0.51%)
USD |
NASDAQ |
Oct 02, 16:00
67.23
-0.02
(-0.03%)
After-Hours: 20:00
BridgeBio Pharma Market Cap : 13.13B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 13.13B |
| October 01, 2026 | 13.07B |
| September 30, 2026 | 12.85B |
| September 29, 2026 | 12.88B |
| September 28, 2026 | 13.01B |
| September 25, 2026 | 12.80B |
| September 24, 2026 | 12.94B |
| September 23, 2026 | 12.83B |
| September 22, 2026 | 13.52B |
| September 21, 2026 | 13.00B |
| September 18, 2026 | 13.01B |
| September 17, 2026 | 13.14B |
| September 16, 2026 | 13.34B |
| September 15, 2026 | 13.36B |
| September 14, 2026 | 14.13B |
| September 11, 2026 | 14.15B |
| September 10, 2026 | 14.16B |
| September 09, 2026 | 14.86B |
| September 08, 2026 | 14.60B |
| September 04, 2026 | 14.62B |
| September 03, 2026 | 14.73B |
| September 02, 2026 | 14.94B |
| September 01, 2026 | 14.95B |
| August 31, 2026 | 14.96B |
| August 28, 2026 | 14.96B |
| Date | Value |
|---|---|
| August 27, 2026 | 15.36B |
| August 26, 2026 | 15.50B |
| August 25, 2026 | 15.70B |
| August 24, 2026 | 15.83B |
| August 21, 2026 | 15.92B |
| August 20, 2026 | 16.20B |
| August 19, 2026 | 16.39B |
| August 18, 2026 | 16.20B |
| August 17, 2026 | 15.60B |
| August 14, 2026 | 15.60B |
| August 13, 2026 | 15.86B |
| August 12, 2026 | 16.37B |
| August 11, 2026 | 16.35B |
| August 10, 2026 | 16.53B |
| August 07, 2026 | 16.50B |
| August 06, 2026 | 16.17B |
| August 05, 2026 | 16.05B |
| August 04, 2026 | 16.06B |
| August 03, 2026 | 15.65B |
| July 31, 2026 | 15.67B |
| July 30, 2026 | 16.08B |
| July 29, 2026 | 16.35B |
| July 28, 2026 | 16.74B |
| July 27, 2026 | 16.46B |
| July 24, 2026 | 16.44B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Ionis Pharmaceuticals, Inc. | 7.212B |
| Pfizer Inc. | 158.43B |
| BioMarin Pharmaceutical, Inc. | 11.07B |
| Vertex Pharmaceuticals, Inc. | 127.87B |
Market Cap Related Metrics
| PS Ratio | 18.30 |
| Price | 67.25 |
| Earnings Yield | -5.31% |